BRAF and neoplasm: By targeting P‐selectin, which is expressed on activated endothelial cells at the tumor site and tumor cells, the NPs showed improved accumulation in 3D spheroids and P‐selectin‐expressing tissues, such as BRAF‐mutated melanomas and BRCA‐mutated breast cancers.